OPTIMISE-CKD: Dapagliflozin is Effective for Patients with C

Results showed treatment with dapagliflozin 10 mg was associated with clinically meaningful attenuations in eGFR slope in patients with CKD and urinary albumin-to-creatinine ratio < 200 mg/g.

Related Keywords

United States , Japan , , University Of Manitoba Navdeep Tangri , Chronic Kidney Disease Initiative , Us Centers For Disease , Drug Administration , Navdeep Tangri , Chronic Kidney Disease , Its Real World Effectiveness Among Patients , Lower Levels , Adv Ther , Disease Control , Chronic Kidney , Ckd , Dapagliflozin , Egfr , Estimated Glomerular Filtration Rate , Urinary Albumin To Creatinine Ratio , Albuminuria ,